Top 5 Government Initiatives Fueling the Growth of POC Immunoassay Analyzers in India: Ken Research

STORY OUTLINE

'Make in India' initiative encourages domestic production of medical devices, including POC Immunoassay Analyzers, to make India a hub for affordable healthcare technology.
National Health Mission is setup to establishes health and wellness centers with diagnostics, driving demand for POC Immunoassay Analyzers in untouched regions.
Ayushman Bharat scheme, a Universal health coverage scheme which improves access to quality healthcare, boosting growth in the POC Immunoassay Analyzer market.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana provides affordable generic medicines, saving costs, and stimulating the Immunoassay Analyzers market.
Promotion of Medical Device Parks which aims to boost domestic manufacturing, reduce import dependence, and foster innovation in the healthcare sector, including Immunoassay Analyzers.

The Indian government, acknowledging the critical role of diagnostics in healthcare delivery, has initiated numerous programs and policies to strengthen the nation's diagnostic capabilities.

Point-of-care (POC) Immunoassay Analyzers, as a vital part of the diagnostic infrastructure, have significantly benefited from these initiatives.

This article provides a comprehensive overview of these government initiatives and their impact on the POC Immunoassay Analyzer market in India.

Click to Read Full Article: India POC Immunoassay Analyzers Market
https://www.kenresearch.com/industry-reports/india-poc-immunoassay-analyzers-market

1. 'Make in India' Initiative

The 'Make in India' initiative, launched in 2014, aims to transform India into a global manufacturing hub.

By encouraging domestic production of medical devices, including POC Immunoassay Analyzers, had significant implications for the healthcare technology sector.

By promoting the manufacturing and production of medical devices within the country, the government has aimed to make India a hub for high-quality, affordable healthcare technology.

2. National Health Mission

Under the National Health Mission, the government aims to establish health and wellness centers across the country to provide comprehensive primary healthcare services, including diagnostics.

 The need for efficient and rapid diagnostic tools at these centers naturally drives the demand for POC Immunoassay Analyzers.

The NHP 2017 outlines a significant emphasis on early screening and diagnosis of diseases. It calls for an increase in investment in diagnostic facilities, especially in rural and underserved regions.

This policy has promoted the usage and distribution of immunoassay analyzers across the country.

To learn more about this report Download A Free Sample Report
https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2NTg5

3. Ayushman Bharat.

Ayushman Bharat, also known as the Pradhan Mantri Jan Arogya Yojana (PMJAY), is a program launched by the Indian Government in 2018.

The scheme aims to provide health insurance coverage of up to 500,000 rupees per family per year to over 100 million families, approximately 500 million beneficiaries.

The scheme covers secondary and tertiary care hospitalization across public and private empaneled hospitals in India.

Ayushman Bharat is a significant initiative in India's journey towards universal health coverage.

By making healthcare accessible and affordable, particularly for the country's poor and vulnerable populations, improving access to quality health services, thus fueling growth in the POC Immunoassays Analyzers Market.

4. Pradhan Mantri Bhartiya Janaushadhi Pariyojana

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is a campaign launched by the Government of India in 2008, aimed at providing quality medicines at affordable prices to the masses through dedicated outlets known as Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJK).

There more than 7,500 PMBJKs across India.

PMBJP is an important move towards providing accessible and affordable healthcare to India's population.

It focuses on offering over 900 high-quality generic medicines covering a wide range of diseases at significantly lower prices than branded equivalents.

The program has resulted in substantial savings for the citizens, thus fueling growth in the Immunoassays analyzers market in India.

For Know more about competition landscape Request free 30 minutes analyst call
https://www.kenresearch.com/book-a-discovery-call.php?Frmdetails=NTk2NTg5

5. Promotion of Medical Device Parks

The Indian government was actively promoting the establishment of medical device parks to boost the domestic manufacturing of medical devices.

 In 2020, the government approved a scheme to promote medical device parks in four states - Kerala, Andhra Pradesh, Tamil Nadu, and Himachal Pradesh.

The parks are expected to benefit from a financial investment of about INR 400 Crores (approximately 54 million USD) to provide world-class infrastructure and facilities.

The promotion of medical device parks is an important part of India's efforts to bolster its healthcare industry.

These parks will serve as hubs for the production of high-quality medical devices, reducing dependence on imports and fostering innovation in the sector.

By encouraging local manufacturing, the initiative aims to bring down the cost of medical devices, increase their accessibility, and stimulate job creation.

It's a strategic move towards self-reliance and boosting the domestic economy in the healthcare sector including the Immunoassays Analyzers market.

Conclusion:

Government initiatives have played a critical role in shaping the POC Immunoassay Analyzer market in India. As these initiatives continue to unfold, their impact on the market is set to increase, paving the way for more accessible, affordable, and rapid diagnostics for the Indian population.

India.

Ken Research is a Market Research and Consulting Firm, based out of India, Indonesia and UAE. Since 2011, we have been assisting clients globally with our Syndicate and Bespoke Market Research and Advisory Services.

This release was published on openPR.